Abstract
Resistance to beta lactam antibiotics is the most common cause for beta-lactamase production. Increasing number of extended spectrum beta-lactamase (ESBL) producers has reduced the treatment options which resulted in emergence of multidrug resistant strains, treatment failure and hence increased mortality. To detect phenotypically, ESBL producers in Gram negative isolates from different samples and to know their susceptibility pattern. A retrospective study of Gram negative isolates was conducted. Total of 521 isolates were isolated from various samples. They were processed and identified by standard procedures. The antibiotic susceptibility testing was performed by Kirby- Bauer disc diffusion method using CLSI guidelines. ESBL was detected by combination disk test. A total of 521 Gram negative isolates were isolated which included E. coli, Klebsiella pneumoniae, Citrobacter spp., Enterobacter spp., Proteus spp. and Acinetobacter spp. Pseudomonas aeruginosa. Of 521 isolates tested, ESBL was detected in 329 (63.1%) isolates. These isolates showed maximum susceptibility to piperacillin- tazobactam (86%) followed by imipenem (78.4%), amikacin (63.5%), cotrimoxazole (54.4%), ciprofloxacin (51%), amoxi-clav (44.9%), cefepime (44.1%), gentamicin (38.9%), cefoxitin (34.9%) and ampicillin (19.1%). ESBL producers which are resistant to beta lactam antibiotics have become a major problem. Detection of these beta-lactamase enzymes by simple disk method and its reporting will help clinicians in prescribing proper antibiotics.
Publisher
Journal of Pure and Applied Microbiology
Subject
Applied Microbiology and Biotechnology,Microbiology,Biotechnology
Reference25 articles.
1. 1. Khan MN, Srivastava P, Chophi V, Nirwan PS. Prevalence of ESBL and AmpC β-Lactamase in Gram Negative Bacilli in various Clinical Samples at Tertiary Care Hospital. International Research Journal of Medical Sciences. 2015;3(8):1-6.
2. 2. Baguma A, Atek K, Joel B. Prevalence of Extended-Spectrum Beta-Lactamases Producing Microorganisms in Patients Admitted at KRRH, Southwestern Uganda. International Journal of Microbiology. 2017;2017:1-5. doi: 10.1155/2017/3183076
3. 3. Rugved Kulkarni, Vaishali Dohe, Dnyaneshwari Ghadge, Arvind Bhore. A study of extended spectrum betalactamase (ESBL) producers in clinical isolates. Medical Journal of Western India. 2013;41(1):18-22.
4. 4. Vatkar VS, Shadija PG, Ghosh SJ. Prevalence of ESBL Producers in Family Enterobacteriaceae Isolated from D. Y. Patil Medical College & Hospital, Kolhapur. Journal of Evolution of Medical and Dental Sciences. 2015;4(70):12241-12245. doi: 10.14260/jemds/2015/1764
5. 5. Dalela G. Prevalence of Extended Spectrum Beta-Lactamase (ESBL) Producers among Gram Negative Bacilli from Various Clinical Isolates in a Tertiary Care Hospital at Jhalawar, Rajasthan. J Clin Diagn Res. 2012;6(2):182-187.